[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Femasys Inc (FEMY)

Femasys Inc (FEMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,773
  • Shares Outstanding, K 60,391
  • Annual Sales, $ 2,290 K
  • Annual Income, $ -18,630 K
  • EBIT $ -16 M
  • EBITDA $ -16 M
  • 60-Month Beta -2.26
  • Price/Sales 10.65
  • Price/Cash Flow N/A
  • Price/Book 3.35
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.27
  • Most Recent Earnings $0.00 on 05/08/26
  • Next Earnings Date 08/14/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.23
  • Growth Rate Est. (year over year) +434,447.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3501 +8.94%
on 04/30/26
0.4799 -20.53%
on 05/06/26
-0.0196 (-4.89%)
since 04/13/26
3-Month
0.3305 +15.40%
on 03/30/26
0.6299 -39.45%
on 03/17/26
-0.1268 (-24.95%)
since 02/13/26
52-Week
0.3067 +24.36%
on 08/26/25
1.1100 -65.64%
on 11/11/25
-0.7186 (-65.33%)
since 05/13/25

Most Recent Stories

More News
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSGâ„¢ Catheter

ATLANTA, May 13, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective...

FEMY : 0.3814 (+1.14%)
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

ATLANTA, May 08, 2026 (GLOBE NEWSWIRE) --   Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective...

FEMY : 0.3814 (+1.14%)
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

ATLANTA, April 22, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective...

FEMY : 0.3814 (+1.14%)
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio

-- Partnership with AMI Technologies Positions FemaSeed ® as a First-Line Infertility Treatment in Israel, Expanding Market Access to Innovative Fertility Solutions --  ATLANTA, April 16, 2026...

FEMY : 0.3814 (+1.14%)
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth

ATLANTA, April 01, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective...

FEMY : 0.3814 (+1.14%)
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update

ATLANTA, March 31, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective...

FEMY : 0.3814 (+1.14%)
Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors

ATLANTA, March 18, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective...

FEMY : 0.3814 (+1.14%)
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment

-- Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, following positive clinical data -- ATLANTA, March 10,...

FEMY : 0.3814 (+1.14%)
Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access

-- FemBloc becomes the latest Femasys product to achieve MDSAP certification, building on a proven track record of compliance -- ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:...

FEMY : 0.3814 (+1.14%)

Business Summary

Femasys Inc.is a biomedical company focused on transforming women's healthcare by developing novel solutions as well as providing significant clinical impact to address severely underserved areas. The company's lead product candidates offer FemBloc and FemaSeed. Femasys Inc. is based in ATLANTA.

See More

Key Turning Points

3rd Resistance Point 0.4273
2nd Resistance Point 0.4135
1st Resistance Point 0.3975
Last Price 0.3814
1st Support Level 0.3677
2nd Support Level 0.3539
3rd Support Level 0.3379

See More

52-Week High 1.1100
Fibonacci 61.8% 0.8031
Fibonacci 50% 0.7084
Fibonacci 38.2% 0.6136
Last Price 0.3814
52-Week Low 0.3067

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.